Therapeutic Solutions International has patented a method for preventing memory loss during neuroinflammation by administering a combination of pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate. The composition inhibits inflammation-associated memory dysfunction in patients. GlobalData’s report on Therapeutic Solutions International gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Therapeutic Solutions International, Cancer immunotherapy was a key innovation area identified from patents. Therapeutic Solutions International's grant share as of May 2024 was 30%. Grant share is based on the ratio of number of grants to total number of patents.
Memory loss prevention during neuroinflammation using therapeutic compositions
A recently granted patent (Publication Number: US11957727B2) discloses a method for inhibiting inflammation-associated memory dysfunction. The method involves identifying a patient suffering from this condition and administering a composition containing specific ingredients such as epigallocatechin-3-gallate, thymoquinone, sulforaphane, and pterostilbene. These components are delivered at a specific dosage and frequency to effectively inhibit inflammation-associated memory dysfunction in the patient.
Furthermore, the patent claims specify various aspects of neural inflammation, particularly microglial activation, as key targets for the method. This includes upregulation of markers such as HLA II, IL-10 production, CD40, CD80, CD86, and nitric oxide production in microglia. The method also addresses inflammation-associated memory dysfunction caused by enhanced production of specific metabolites like quinilonic acid and kyneurinin, which are associated with indolamine 2,3-deoxygenase. By targeting these inflammatory pathways and metabolites, the method aims to provide a novel approach to managing memory dysfunction associated with inflammation.
To know more about GlobalData’s detailed insights on Therapeutic Solutions International, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
